Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors

[1] Chernyak V(2018)Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients Radiology 289 816-830

[2] Fowler KJ(2018)cHCC-CCA: consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentiation Hepatology 68 113-126

[3] Kamaya A(2018)LI-RADSM(LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma Abdom Radiol (NY) 43 149-157

[4] Brunt E(2018)Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis Abdom Radiol (NY) 43 13-25

[5] Aishima S(2012)Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers Liver Int 32 1156-1164

[6] Clavien PA(2015)Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress Hepatic Oncol 2 255-273

[7] Fowler KJ(2006)Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection Hepatology 43 1317-1325

[8] Potretzke TA(2017)Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the Liver Imaging Reporting and Data System version 2014 Radiology 286 158-172

[9] Hope TA(1977)The measurement of observer agreement for categorical data Biometrics 33 159-174

[10] Costa EA(2016)Differences in Liver Imaging and Reporting Data System categorization between MRI and CT AJR Am J Roentgenol 206 307-312

[1] Chernyak V(2018)Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients Radiology 289 816-830

[2] Fowler KJ(2018)cHCC-CCA: consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentiation Hepatology 68 113-126

[3] Kamaya A(2018)LI-RADSM(LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma Abdom Radiol (NY) 43 149-157

[4] Brunt E(2018)Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis Abdom Radiol (NY) 43 13-25

[5] Aishima S(2012)Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers Liver Int 32 1156-1164

[6] Clavien PA(2015)Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress Hepatic Oncol 2 255-273

[7] Fowler KJ(2006)Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection Hepatology 43 1317-1325

[8] Potretzke TA(2017)Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the Liver Imaging Reporting and Data System version 2014 Radiology 286 158-172

[9] Hope TA(1977)The measurement of observer agreement for categorical data Biometrics 33 159-174

[10] Costa EA(2016)Differences in Liver Imaging and Reporting Data System categorization between MRI and CT AJR Am J Roentgenol 206 307-312